NCT05321316
Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Enrollment increased: 20 → 40 participants
- Eligibility criteria expanded, about 66 words
- Start date changed from estimate of May 31, 2026 to May 31, 2025
- Study title expanded, about 1 word
- Notable Primary and study completion dates: Dec 2024 to Dec 2026
- Start date: May 31, 2022 to May 31, 2026
- Notable Primary and study completion dates: Dec 2023 to Dec 2024v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Apr 2022 to May 31, 2022
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Standardized uptake value(SUV)
Timeframe: 2 years
Arms and interventions
68Ga-NT-BCHExperimental
Imaging cohort All study participants will be allocated to this arm (single-arm study). Study participants will undergo 68Ga-NT-BCH PET/CT scan.
Drugs: 18F-FDG
Sites
1 site in 1 country
- Beijing Cancer HospitalBeijing, Beijing Municipality, China